Keywords: GAG; Glycosaminoglycan; HA; Hyaluronic Acid; CS; Chondroitin Sulfate; DS; Dermatan Sulfate; HS; Heparan Sulfate; HIV; Human Immunodeficiency Virus; gp120; Glycoprotein 120; CD4; Cluster of Differentiation 4; AMAC; 2-Aminoacridone; DMSO; Dimethyl Sulfoxide
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: HIV; Human Immunodeficiency Virus; rDNA; recombinant DNA technology; MHC; major histocompatibility complex; HLA; human leukocyte antigen; PSSM; Position Specific Scoring Matrices; ANN; Artificial Neuronal Networks; QM; quantitative matrices; KISS; Kernel-
Keywords: APC; professional antigen presenting cell; bGal; beta-galactosidase; CD; cluster of differentiation; CpG; CpG oligodeoxynucleotides; CT; cholera toxin; CTL; cytotoxic T cell; CSSS; cyanoacrylate skin surface stripping; dDC; dermal dendritic cell; DNA; deo
Keywords: HIV; human immunodeficiency virus; CD4; cluster of differentiation 4; ELISA; enzyme-linked immunosorbent assay; FITC; fluorescein isothiocyanate; Ab; antibody; Fusion peptide; In vivo expression; gp120; HIV detection; Early stages;
Keywords: Buprenorphine; Methadone; HIV-1; gp120; Physical dependence
Characterization of twin-cysteine motif in the V2-loop region of gp120 in primate lentiviruses
Keywords: Twin-cysteine motif (TCM); V2-loop; Gp120; Envelope trimer; Primate lentiviruses (PLV); Human immunodeficiency viruses (HIV); Simian immunodeficiency viruses (SIV);
HIV glycoprotein gp120 enhances mesenchymal stem cell migration by upregulating CXCR4 expression
Keywords: Mesenchymal stem cells; HIV; gp120; Cell migration; CXCR4; Focal adhesion kinase (FAK);
Contribution of the gp120 V3 loop to envelope glycoprotein trimer stability in primate immunodeficiency viruses
Keywords: Hydrophobic patch; V3 loop; gp120; HIV-1; HIV-2; Simian immunodeficiency virus (SIV); Primate immunodeficiency viruses (PIV);
Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters
Keywords: Tat; Gp120; Pediatric HIV-1; Spatial learning; Stereology; Hippocampus;
The alpha helix 1 from the first conserved region of HIV1 gp120 is reconstructed in the short NQ21 peptide
Keywords: HIV1; gp120; Secondary structure; SERS spectroscopy; Fluorescence; Native gel electrophoresis;
Limonene reduces hyperalgesia induced by gp120 and cytokines by modulation of IL-1 β and protein expression in spinal cord of mice
Keywords: Mechanical hyperalgesia; gp120; IL-1β; TNF-α;
Tryptophan 375 stabilizes the outer-domain core of gp120 for HIV vaccine immunogen design
Keywords: Outer domain (OD); Gp120; HIV-1 subtype C; 375W; Structure-based design; Immunogenicity; Vaccine;
Immunofocusing using conformationally constrained V3 peptide immunogens improves HIV-1 neutralization
Keywords: CD4bs; CD4 binding site; CFA; Complete Freund's Adjuvant; IFA; Incomplete Freund's Adjuvant; mAb; monoclonal antibody; gp120; V3; HIV vaccine; Immunofocusing; Neutralizing antibodies;
HIV-1 subtype CRF01_AE and B differ in utilization of low levels of CCR5, Maraviroc susceptibility and potential N-glycosylation sites
Keywords: HIV; AIDS; CD4; gp120; CCR5; PNGS; Subtype B; CRF01_AE; Maraviroc; Envelope;
Sulfotyrosine dipeptide: Synthesis and evaluation as HIV-entry inhibitor
Keywords: HIV entry inhibitor; Sulfotyrosine; Sulfotyrosine dipeptide; Sulfopeptide; gp120; Antiviral therapy; Protein sulfation
Fragments of the V1/V2 domain of HIV-1 glycoprotein 120 engineered for improved binding to the broadly neutralizing PG9 antibody
Keywords: gp120; glycoprotein 120 from HIV-1; rgp120; recombinant gp120; V1,V2,V3; the first second and third variable regions of gp120; C1,C2,C3; the first second and third constant regions of gp120; bN-mAb; broadly neutralizing monoclonal antibody; bNAb; broadly
Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated Cytotoxicity
Keywords: HIV-1; Envelope glycoproteins; gp120; CD4; CD4-bound conformation; Non-neutralizing antibodies; ADCC; CD4-mimetics; Bystander killing
HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders
Keywords: HAND; HIV-associated neurocognitive disorders; DNM1L; dynamin 1-like; MFN; mitofusin; ECAR; extracellular acidification rate; ANI; asymptomatic neurocognitive impairment; MND; minor neurocognitive disorder; HAD; HIV-associated dementia; HIV; Mitochondria;
Fluorescent CD4 probe for potential HIV-1 gp120 protein detection
Keywords: HIV-1; human immunodeficiency virus type 1; mD1; mutant CD4 domain 1; FRET; Förster resonance energy transfer; Acd; acridon-2-ylalanine; EB; Evans blue; PET; photoinduced electron transfer; Fluorescent CD4; Acridon-2-ylalanine; FRET; gp120; HIV detection
Rapid screening and identification of active ingredients in licorice extract interacting with V3 loop region of HIV-1 gp120 using ACE and CE-MS
Keywords: HIV-1; gp120; ACE; CE-MS; Licorice
Stoichiometric parameters of HIV-1 entry
Keywords: HIV-2; gp120; Env; Entry; Relative infectivity; CD4; CCR5; CXCR4;
Engineering and exploitation of a fluorescent HIV-1 gp120 for live cell CD4 binding assays
Keywords: ART; anti-retroviral therapy; BNAbs; broadly neutralizing antibodies; CS; cellulose sulfate; ER; endoplasmic reticulum; FP; fluorescent protein; FRAP; fluorescence recovery after photobleaching; gp120; HIV-1 envelope glycoprotein; MR; maraviroc; PHA; phyt
Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee
Keywords: HIV-1; Gp120; V2; RV-144; Antibody maturation; Germline; Unmutated ancestor
GSK3β-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity
Keywords: CNS; central nervous system; HIV-1; human immunodeficiency virus-1; HAND; HIV-1-associated neurocognitive disorders; cART; combination antiretroviral therapy; Tat; trans-activator of transcription; gp120; glycoprotein 120; GSK3β; glycogen synthase kinase
HIV-1 gp120 dimers decrease the overall affinity of gp120 preparations for CD4-induced ligands
Keywords: HIV; gp120; gp120 dimers; Surface plasmon resonance; FPLC; CD4-induced epitopes;
CNTF regulates neurite outgrowth and neuronal migration through JAK2/STAT3 and PI3K/Akt signaling pathways of DRG explants with gp120-induced neurotoxicity in vitro
Keywords: Ciliary neurotrophic factor; gp120; Neurotoxicity; Neuropathy; HIV; Dorsal root ganglion;
Characterization of a monoclonal antibody to a novel glycan-dependent epitope in the V1/V2 domain of the HIV-1 envelope protein, gp120
Keywords: Gp120; Glycosylation; Epitope; V1/V2 domain; HIV; Monoclonal antibody;
Structural dynamics of V3 loop in a trimeric ambiance, a molecular dynamics study on gp120-CD4 trimeric mimic
Keywords: gp120; Molecular dynamics; V3 loop; Co-receptor recognition;
Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamers
Keywords: ssDNA CD4 aptamer; gp120; HIV infection prevention; Hybrid SELEX; Specific blocking;
Neonatal intrahippocampal HIV-1 protein Tat1–86 injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation
Keywords: Tat1–86; gp120; HIV-1; Developmental delay; Cytokines; Neurotoxicity
Discovery of small molecular inhibitors targeting HIV-1 gp120–CD4 interaction drived from BMS-378806
Keywords: AIDS; HIV-1; BMS-378806; NBD-556; gp120; Attachment inhibitors; Drug designHIV-1, human immunodeficiency virus 1; gp120, glycoprotein 120; SAR, structure–activity relationship; AIDS, acquired immunodeficiency syndrome; UNAIDS, Joint United Nations Program
Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequence
Keywords: HIV-1; gp120; Outer domain; Vaccine; V3; Neutralizing antibody;
Multi-parameter exploration of HIV-1 virus-like particles as neutralizing antibody immunogens in guinea pigs, rabbits and macaques
Keywords: HIV; Vaccine; Antibody; Neutralization; VLPs; gp120; gp41; Env;
Purification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity
Keywords: Empigen BB; gp120; HIV envelope protein; Surface plasmon resonance; Vaccinia virus expression;
The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry
Keywords: HIV-1; gp120; Tat; Virus entry; Peptide;
HIV gp120 induced gene expression signatures in vaginal epithelial cells
Keywords: HIV; gp120; Vagina; Proteases; Inflammation; Microarray;
Research reportBehavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice
Keywords: HIV; Methamphetamine; gp120; Inhibition; Behavioral Pattern Monitor;
The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets
Keywords: HIV-1; Maraviroc; Resistance; T-cell; Macrophage; Tropism; Env; gp120
Characterization of a dual-tropic Human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2
Keywords: HIV-1; Envelope glycoproteins; Entry; Tropism; Gp120; V3 loop; CCR5; CXCR4; Chemokine receptor; Trimer
Use of the anti-inflammatory cytokine interleukin-11 to reverse HIV-1gp120 repression of a natural killer cell line
Keywords: HIV-1; NK cells; gp120; IL-11; Cytotoxicity; IFN-γ; NK-92MI; STAT-3; Apoptosis; Bcl-XL;
Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens
Keywords: HIV-1; Human monoclonal antibody; IgM; gp120; Envelope glycoprotein; Immunogen
Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice
Keywords: T-cell vaccine; Gp120; CD8+ CTL; Long-term memory; Transgenic HLA-A2 mice
Fusion proteins of HIV-1 envelope glycoprotein gp120 with CD4-induced antibodies showed enhanced binding to CD4 and CD4 binding site antibodies
Keywords: HIV-1; gp120; Stabilization; CD4; CD4i antibody; CD4bs antibody
Isobaric tagging-based quantification by mass spectrometry of differentially regulated proteins in synaptosomes of HIV/gp120 transgenic mice: Implications for HIV-associated neurodegeneration
Keywords: HAND; HIV-associated neurocognitive disorders; TMT; tandem mass tag; MS/MS; tandem mass spectrometry; PQD; pulsed-Q dissociation; HAART; Highly-Active Antiretroviral Therapy; ICAT; Isotope Coded Affinity Tag; PSD95; postsynaptic density protein 95; Proteo
Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12
Keywords: HIV-1; Gp120; Structure; B12; Neutralization
Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120
Keywords: AIDS; Acquired immune deficiency syndrome; ARV; Antiretroviral; CADA; Cyclotriazadisulfonamide; CBA(s); Carbohydrate-binding agent(s); CPE; Cytopathic effect; DCs; Dendritic cells; DC-SIGN; Dendritic cell-specific ICAM-3 grabbing non-integrin; DS5000/8000
Intrathecal cannabilactone CB2R agonist, AM1710, controls pathological pain and restores basal cytokine levels
Keywords: Cannabinoid; CCI; Paraffin immunohistochemistry; Rat; Spectral analysis; gp120;
AFM force measurements of the gp120–sCD4 and gp120 or CD4 antigen–antibody interactions
Keywords: Atomic force microscopy (AFM); Human immunodeficiency virus (HIV); Entry inhibitor; Soluble CD4 (sCD4); gp120; Neutralizing antibody
HIV-1 envelope protein gp120 up regulates CCL5 production in astrocytes which can be circumvented by inhibitors of NF-κB pathway
Keywords: gp120; CCL5; NeuroAIDS; Neuroinflammation;
A versatile vector for the production of pseudotyped viruses expressing gp120 antigens from different clades of primary HIV-1 isolates
Keywords: HIV-1; Envelope protein; gp120; Pseudotyped virus; Neutralizing antibody